{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T06:06:56Z","timestamp":1760249216072},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.4065\/74.5.490","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"490-494","source":"Crossref","is-referenced-by-count":14,"title":["Amyloidosis: Recognition, Confirmation, Prognosis, and Therapy"],"prefix":"10.4065","volume":"74","author":[{"given":"Morie A.","family":"Gertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.5.490_bib1","first-page":"552","article-title":"The diagnosis, natural history and treatment of amyloidosis: the Goulstonian Lecture 1995","volume":"31","author":"Hawkins","year":"1997","journal-title":"J R Coll Physicians Lond"},{"key":"10.4065\/74.5.490_bib2","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.4065\/74.5.490_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.56.11.631","article-title":"Diagnosis and treatment of amyloidosis","volume":"56","author":"Hawkins","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/74.5.490_bib4","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/archinte.1992.00400230061010","article-title":"Dialysis support of patients with primary systemic amyloidosis: a study of 211 patients","volume":"152","author":"Gert","year":"1992","journal-title":"Arch intern Med"},{"key":"10.4065\/74.5.490_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.510250122","article-title":"Hepatic amyloidosis: clinical appraisal in 77 patients","volume":"25","author":"Gertz","year":"1997","journal-title":"Hepatology"},{"key":"10.4065\/74.5.490_bib6","first-page":"313","article-title":"Prognostic value of urinary protein in primary systemic amyloidosis (AL)","volume":"94","author":"Gertz","year":"1990","journal-title":"Am J Clin Palhol"},{"key":"10.4065\/74.5.490_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0049-0172(05)80006-X","article-title":"Amyloidosis: prognosis and treatment","volume":"24","author":"Gertz","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.4065\/74.5.490_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"W Engl J Med"},{"key":"10.4065\/74.5.490_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","article-title":"Response rates and survival in primary systemic amyloidosis","volume":"77","author":"Gertz","year":"1991","journal-title":"Blood"},{"key":"10.4065\/74.5.490_bib10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.5.490_bib11","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: sur vival and responses in 25 patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611651306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611651306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:10:03Z","timestamp":1589505003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611651306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0025619611651306"],"URL":"https:\/\/doi.org\/10.4065\/74.5.490","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}